FLUAD (Seqirus Inc.)


Welcome to the PulseAid listing for the FLUAD drug offered from Seqirus Inc.. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: Seqirus Inc.
NON-PROPRIETARY NAME: A/Singapore/GP1908/2015 IVR-180 (H1N1) (an A/Michigan/45/2015 (H1N1)pdm09-like virus), A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus), and B/Brisbane/60/2008, wild typ
SUBSTANCE NAME: INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS
TYPE: VACCINE
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2017-07-01
END MARKETING DATE: 2018-06-30


FLUAD VACCINE Details:

Item DescriptionFLUAD from Seqirus Inc.
LABELER NAME: Seqirus Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL)
START MARKETING DATE: 2017-07-01
END MARKETING DATE: 2018-06-30
PRODUCT ID: 70461-002_8846ea55-4e1f-41fc-909b-84c612ab5b87
PRODUCT NDC: 70461-002
APPLICATION NUMBER: BLA125510

Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline Biologicals SAFLUARIX QUADRIVALENT
Seqirus Inc.FLUAD